Margin collapse & guidance cut; KUSUM delay threatens H2 recovery
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Prior FY27 guidance: 22-23% EBITDA, 15-16% PAT. Q1 delivered 15.7% EBITDA, 11.2% PAT. Margin guidance cut mid-year. Revenue phasing in line with back-ended plan.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered severe margin compression (15.7% OPM vs. 22-23% prior guidance) and PAT collapse (-42.8% YoY) driven by Magel Tyala competitive pricing (9% realization hit) and geopolitical input costs. Management cut FY27 margin guidance but maintained 20-25% revenue growth, requiring massive H2 ramp and PM KUSUM 2.0 launch (timing unconfirmed). Long-term PM Surya Ghar diversification (₹800-1,000 Cr target) is strategically sound but execution unproven. Near-term risks high.
₹473.6 Cr
Revenue · −7.9% YoY₹54.1 Cr
Reported PAT · −42.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Magel Tyala competitive bidding caused 9% price realization decline
METQ1 OPM 15.7% vs. prior 22-23% guidance; management attributed 9% to pricing, 3.5% to costs, 1.5% to leverage—total ~7.9% impact
Q1 revenue decline in line with back-ended growth phasing
METQ1 revenue -7.9% YoY; management claims aligned with 'moderate H1 decline' per prior guidance and expects H2 ramp
20-25% FY27 revenue growth remains on track
OVERSTATEDQ1 shows -7.9% YoY; requires ₹1,800+ Cr in Q2-Q4 to hit 20% growth target. Contingent on PM KUSUM 2.0 launch (not yet confirmed) and PM Surya Ghar ramp
FY27 operating EBITDA margin 22-23%, PAT margin 15-16%
MISSRevised to 15-17% EBITDA and 11-13% PAT for FY27. Clear downgrade. Q1 delivered 15.7% OPM and 11.2% PAT
Diversification into PM Surya Ghar will offset PM KUSUM dependency
Partial1GW solar capacity by end Q2; 200k installation target; revenue ₹800-1,000 Cr for rest of FY27. Strategy credible but unproven; lower margin than core business
Earnings quality
What changed since the last call
Operating EBITDA margin guidance reduced
DowngradeFY27 cut from 22-23% to 15-17%. 9% Magel Tyala price impact and 3.5% geopolitical cost inflation drove Q1 miss to 15.7%.
PAT margin guidance reduced
DowngradeFY27 cut from 15-16% to 11-13%. Q1 delivered 11.2%, placing quarter at lower end of new guidance range.
Working capital cycle deteriorated sharply
DowngradeCash conversion cycle 244 days vs. 172 days prior; receivable days 229 vs. 155. ₹305 Cr receivables not yet due from government. Liquidity pressure.
PM Surya Ghar vertical launched
NewDedicated business head appointed; 1GW solar capacity targeting end Q2; 200k installations FY27 target (~₹800-1,000 Cr revenue).
FY27 revenue growth guidance maintained
Neutral20-25% maintained despite Q1 -7.9% YoY start. Requires aggressive H2 ramp and PM KUSUM 2.0 launch. Execution risk elevated.
The Q&A
Retail investor (Manish Gadia) pressed hard on execution track record (stock down 50% from IPO, guidance good but delivery poor). Analysts (Disha, Karan, Pawan) grilled margin math, cost mitigation, and PM Surya Ghar profitability. Management defended with 'temporary' and 'external factors' narrative but took little accountability. Q&A tone was defensive but not evasive.
Execution vs. guidance gap — Manish Gadia, Individual Investor
PartialCompany fundamentally strong. External factors (PM KUSUM delay, Magel Tyala bidding competition, geopolitical costs) are temporary. FY28-29 will be clear and very good with full team dedication.
Margin defense without KUSUM — Disha, Sapphire Capital
AnsweredValue engineering recovering lost margin. PM Surya Ghar target 200k installations. Magel Tyala T6 bid opens 7-10 days. Clear visibility on 20-25% growth even without KUSUM Q2.
Margin bifurcation quantified — Karan, Choice Institutional Equities
Answered8-9% from Magel Tyala price bidding; 3-3.5% from geopolitical costs; 1-1.5% from leverage. Total ~7.9% EBITDA impact. Value engineering mitigated further deterioration.
Capex timeline and margin basis — Prakhar, Choice Institutional Equities
Answered1GW commercial production first/second week September (Q2 end). 15-17% based on current bids, conservative calculation. If KUSUM comes, margins could improve slightly.
Receivables collection status — Dheeraj Ram, 360 ONE Capital
PartialVery few receivables came Q1. Better expected Q2 (state commitments made). Q3 will see very big changes in receivables collection.
Revenue math: growth vs PM Surya Ghar contribution — Pawan Kumar, Shade Capital
PartialQ1 ₹474 Cr mostly pumping. PM Surya Ghar revenue starts Q2 onwards (₹800-1,000 Cr for Q2-Q4). Plus pump orders ₹500+ Cr, wires ₹70-100 Cr. Total ₹2,000+ Cr achievable.
Guidance
FY27 revenue growth 20-25% over FY26
MediumBack-ended phasing; H1 expected moderate decline. Q1 -7.9% YoY in line with plan. Requires PM KUSUM 2.0 launch and PM Surya Ghar ramp Q2 onwards.
Operating EBITDA margin FY27: 15-17%
MediumCut from prior 22-23%. Q1 delivered 15.7%. Conservative calculation; assumes continued competitive bidding and cost inflation.
PAT margin FY27: 11-13%
LowCut from prior 15-16%. Q1 delivered 11.2%. Q2-Q4 must improve to reach upper end of range.
Total FY27 capex ₹360-400 Cr
HighPump & motor plant expansion by Q3 FY27. 1GW solar module capacity by end Q2. Within IPO proceeds allocation.
Risks the call surfaced
PM KUSUM 2.0 launch delay
HighPM KUSUM 2.0 repeatedly delayed; expected August 2026 but no official confirmation. Any further postponement cascades Q2-Q4 revenue miss and 20-25% FY27 growth target at risk.
Competitive pricing collapse
HighMagel Tyala scheme saw 9% price realization decline YoY due to increased bidder participation (new entrants and incumbents seeking volume). Aggressive bidding to gain market share threatens margin recovery.
Geopolitical input cost inflation
HighElevated raw material costs (copper, steel, electronic components) from ongoing geopolitical tensions add 3-3.5% margin pressure in Q1. No clear visibility on normalization timeline.
Working capital deterioration
HighCash conversion cycle ballooned to 244 days from 172 days. ₹305 Cr of ₹530 Cr receivables not yet due from government counterparties. Delays in state payments extend cash needs for capex and operations.
Revenue growth execution risk
Medium20-25% FY27 growth requires substantial Q2-Q4 ramp. Q1 -7.9% YoY means remaining 3 quarters must contribute ₹1,800+ Cr on ₹474 Cr Q1 base. PM Surya Ghar and channel sales unproven; PM KUSUM timing unconfirmed.
Management
Score 5/10. Candid on challenges (pricing pressure, geopolitics, KUSUM delay) but overuses 'temporary phase' deflection. Margin guidance cuts revealed in Q&A rather than proactively announced. Reactive communication reduces confidence. Prior FY27 guidance 22-23% EBITDA, 15-16% PAT not met in Q1 (delivered 15.7%, 11.2%). Revenue 20-25% growth guidance remains but Q1 -7.9% start leaves narrow margin. Credibility impacted by miss.
1 · August 2026 (Q2)
PM KUSUM 2.0 tender launch; Magel Tyala T6 bid opening
2 · September 2026 (Q2 end)
1GW solar module capacity commercial production online
3 · Q3 FY27
Capex completion; government receivable normalization expected
Near-term risks high.
Informational and educational content only. Not investment advice.